We are proud to announce the workflow system "From genome to drug" will be launched in summer 2017. With the support and financing from Fund Skolkovo the Biosoft's team is currently finishing the development of this unique tool for biomedical data analysis.
LLC “BIOSOFT.RU” took part in the II National Congress on Regenerative Medicine. Due to the organizers of the congress and to the support of Russian Ministry of Industry and Trade, the company’s representatives were able to take part in the exhibition and to make an oral report on one of the conference’s sessions.
LLC “BIOSOFT.RU” will attend the 2nd International conference and exhibition FIZTEH-MED 2015 conducted under the auspices of the Ministry of Industry and Trade of the Russian Federation
The Biosoft project was presented at the StartUp Village 2014 conference, where in the scope of InBioMed competition it was honored with the rank of one of the most attractive investment projects in the biomedical technologies sphere.
Biosoft gets a BB index form the Russian Startup Index (RSI) rating agency
Biosoft project is presented on the Health & Technology 2012 conference